share_log
Reuters ·  May 8 15:58
Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment